BR112020002619A2 - nanoemulsão de ácidos graxos iodados para imageamento de ct - Google Patents

nanoemulsão de ácidos graxos iodados para imageamento de ct Download PDF

Info

Publication number
BR112020002619A2
BR112020002619A2 BR112020002619-0A BR112020002619A BR112020002619A2 BR 112020002619 A2 BR112020002619 A2 BR 112020002619A2 BR 112020002619 A BR112020002619 A BR 112020002619A BR 112020002619 A2 BR112020002619 A2 BR 112020002619A2
Authority
BR
Brazil
Prior art keywords
vivo
contrast agent
nanoemulsion
imaging method
fatty acids
Prior art date
Application number
BR112020002619-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Laurent Vinet
Andrej Babic
Eric Allemann
Original Assignee
University Of Geneva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Geneva filed Critical University Of Geneva
Publication of BR112020002619A2 publication Critical patent/BR112020002619A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicinal Preparation (AREA)
BR112020002619-0A 2017-08-07 2018-07-27 nanoemulsão de ácidos graxos iodados para imageamento de ct BR112020002619A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17185185.0 2017-08-07
EP17185185 2017-08-07
PCT/EP2018/070501 WO2019030024A1 (en) 2017-08-07 2018-07-27 NANOEMULSION OF IODIZED FATTY ACIDS FOR COMPUTER-ASSISTED TOMOGRAPHY (CT) IMAGING

Publications (1)

Publication Number Publication Date
BR112020002619A2 true BR112020002619A2 (pt) 2020-07-28

Family

ID=59564118

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020002619-0A BR112020002619A2 (pt) 2017-08-07 2018-07-27 nanoemulsão de ácidos graxos iodados para imageamento de ct

Country Status (9)

Country Link
US (1) US11654202B2 (enExample)
EP (1) EP3664855A1 (enExample)
JP (1) JP7210542B2 (enExample)
CN (1) CN111194225B (enExample)
AU (1) AU2018314406B2 (enExample)
BR (1) BR112020002619A2 (enExample)
CA (1) CA3072282A1 (enExample)
EA (1) EA202090139A1 (enExample)
WO (1) WO2019030024A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113784734B (zh) * 2019-02-13 2024-09-27 日内瓦大学 用于恶病质的检测的ct造影剂
JP2023536358A (ja) * 2020-08-06 2023-08-24 アディポス エスエー Ｐｅｔ－ｃｔ撮像方法、その撮像方法における使用のための造影剤および医薬組成物
CN112933246A (zh) * 2020-12-17 2021-06-11 太阳雨林（厦门）生物医药有限公司 一种可显影的油制剂及其制备方法
US20240336552A1 (en) * 2021-08-02 2024-10-10 Microvention, Inc. Compounds
EP4423211A1 (en) 2021-10-28 2024-09-04 Adiposs SA Emulsions, compositions for emulsions, methods for making the same and uses thereof
WO2025079088A1 (en) * 2023-10-11 2025-04-17 Bioroot Exploration India Private Limited A contrast agent for computed tomography and process of preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258172A (en) * 1983-12-29 1993-11-02 Rubin Daniel L Iodinated aliphatic emulsions for X-ray contrast
DE3785849T2 (de) 1987-06-11 1993-08-26 Kabi Pharmacia Ab Jod enthaltende emulsion.
US5861367A (en) 1993-08-04 1999-01-19 Colgate Palmolive Company Cleaning and disinfecting composition in microemulsion/liquid crystal form comprising aldehyde and mixture of partially esterified, fully esterified and non-esterified polyhydric alcohols
FR2736549B1 (fr) 1995-07-11 1997-10-10 Louis Jung Esters d'acides gras iodes, acides gras iodes et leurs derives, obtenus par iodohydrination faisant intervenir des derives alkylsilyles avec des iodures alcalins et leurs activites pharmacologiques
DE19936727A1 (de) 1999-08-06 2001-02-08 Henkel Kgaa Niotensidbasiertes wäßriges mehrphasiges Reinigungsmittel
US20050079131A1 (en) * 2003-08-08 2005-04-14 Lanza Gregory M. Emulsion particles for imaging and therapy and methods of use thereof
GB0408684D0 (en) 2004-04-19 2004-05-19 Guy S And St Thomas Hospital N Diagnostic method
SG10201505948VA (en) 2004-12-13 2015-09-29 Amylin Pharmaceuticals Llc Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same
ATE496881T1 (de) 2006-02-15 2011-02-15 Ge Healthcare As Kontrastmittel
US20080319315A1 (en) 2007-06-07 2008-12-25 Beth Israel Deaconess Medical Center Method of reducing interferences in positron emission tomography
US20140065067A1 (en) 2010-12-17 2014-03-06 Universite De Strasbourg Radiopaque iodinated products intended for use medical imaging and their methods
KR101263733B1 (ko) 2011-03-22 2013-05-14 한국과학기술연구원 리피오돌을 함유하는 컴퓨터 단층촬영용 혈관 조영제
CN102166365B (zh) 2011-04-25 2012-10-24 东南大学 一种多模态碘油纳米乳造影剂的制备方法
DE102012204378A1 (de) 2012-03-20 2013-09-26 Bernd Schwegmann Gmbh & Co. Kg Reinigungsmittel auf Mikroemulsionsbasis
CN105592862B (zh) 2013-09-30 2020-09-29 贝朗医疗有限公司 肝脏预饱和及其后造影剂的施用
WO2015127347A1 (en) 2014-02-24 2015-08-27 The Regents Of The University Of California Therapeutic hyperbranched polyglycerol encapsulated biomolecules
US10157462B2 (en) 2016-06-27 2018-12-18 University Of Central Florida Research Foundation, Inc. System and method for image-based quantification of white and brown adipose tissue at the whole-body, organ and body-region levels

Also Published As

Publication number Publication date
JP2020529441A (ja) 2020-10-08
EP3664855A1 (en) 2020-06-17
EA202090139A1 (ru) 2020-08-06
AU2018314406A1 (en) 2020-02-20
WO2019030024A1 (en) 2019-02-14
CN111194225B (zh) 2023-01-13
CA3072282A1 (en) 2019-02-14
CN111194225A (zh) 2020-05-22
JP7210542B2 (ja) 2023-01-23
AU2018314406B2 (en) 2024-08-15
US11654202B2 (en) 2023-05-23
US20210330820A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
BR112020002619A2 (pt) nanoemulsão de ácidos graxos iodados para imageamento de ct
Zhou et al. Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α
AU2020223505B2 (en) CT contrast agent for detection of cachexia
JPH0339045B2 (enExample)
US20200268776A1 (en) Emulsion composition for chemoembolization and method for producing same
JP2009023929A (ja) 微小循環構築の血管種別選択的造影剤および造影方法
US20230284994A1 (en) Pet-ct imaging methods, contrast agents and pharmaceutical compositions for use in said imaging methods
EA043372B1 (ru) Контрастный агент для компьютерной томографии
AU758913B2 (en) Drugs for therapeutic use enabling nuclear magnetic resonance diagnosis by scalar bond
EA045963B1 (ru) Контрастный агент для кт для детекции кахексии
KR900006983B1 (ko) 활성성분으로 3-벤조일옥시-1, 3, 5(10)-에스트라트리엔-17-[4-(p-(비스(2-클로로에틸)아미노)페닐)부타노일옥시]아세테이트를 함유하는 주사약
PT815072E (pt) Agentes de contraste de raios x para a tomografia e a urografia computadorizadas
JPH09268131A (ja) 高濃度核磁気共鳴造影剤

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]